R2WA.F BEXIMCO PHARMA.GDR REGS 1

Healthcare Pharmaceuticals Frankfurt Exchange
0.6254 EUR
Close of Nov 12, 2026
0.3615 0.4000
Market cap
EUR 279M
P/E
3.6x
P/B
0.32x
ROE
15.4%
Dividend yield
8.41%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2026.

Is R2WA.F undervalued?

Graham number

The Graham number of BEXIMCO PHARMA.GDR REGS 1 cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BEXIMCO PHARMA.GDR REGS 1 fundamental analysis

No fundamental analysis for BEXIMCO PHARMA.GDR REGS 1 yet.

BEXIMCO PHARMA.GDR REGS 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BEXIMCO PHARMA.GDR REGS 1

Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin an…

Full company profile